Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Med.

Sec. Hepatobiliary Diseases

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1537227

Heterotaxy Polysplenia Syndrome with Cholangiopancreatic Cancer: A Case Report and Literature Review

Provisionally accepted
Ziye  ChenZiye Chen1Yu-Ann  ChenYu-Ann Chen1Xuedong  WangXuedong Wang1Wenyan  SongWenyan Song2Yadi  GengYadi Geng2Pengfei  WangPengfei Wang1Siming  KongSiming Kong1Jiahong  DongJiahong Dong1*Hui  BaiHui Bai1*Yunfang  WangYunfang Wang1*
  • 1Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China
  • 2Beijing University of Technology, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Heterotaxy polysplenia syndrome is a rare condition characterized by multiple abnormal spleens and irregular placement of various organs. Some patients have been documented as developing various types of cancers, although the association with heterotaxy polysplenia syndrome remains uncertain. Most cases of heterotaxy polysplenia syndrome are isolated anomalies, but there are rare instances where it appears in closely related individuals, suggesting possible genetic inheritance. We report the case of a 36-year-old woman with heterotaxy polysplenia syndrome, who presented with choledocholithiasis, thickening and stenosis of the hepatic portal bile duct wall, duodenal atresia, and congenital pancreatic insufficiency. Following recovery from a COVID-19 infection, the patient incidentally identified a mass in the upper abdomen. Pathological examination revealed the mass to be a poorly differentiated adenocarcinoma of pancreaticobiliary origin. Additionally, a familial pattern of situs inversus and breast cancer was observed. In this report, we also provide a comprehensive literature review to enhance the understanding of heterotaxy polysplenia syndrome and to explore the potential association between this condition and tumor development. Our report contributes to the current knowledge about heterotaxy polysplenia syndrome and its potential association with tumors. Effective integration of clinical diagnostic information, exploration of precise means of diagnosing and treating rare diseases, and incorporation of the patient's familial background are promising for future research and clinical interventions.

Keywords: heterotaxy polysplenia syndrome1, congenital pancreatic insufficiency2, COVID-19 3, duodenal atresia4, cholangiopancreatic cancer5

Received: 30 Nov 2024; Accepted: 07 May 2025.

Copyright: © 2025 Chen, Chen, Wang, Song, Geng, Wang, Kong, Dong, Bai and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jiahong Dong, Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China
Hui Bai, Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China
Yunfang Wang, Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.